Michael J. Lazar, MD was an early user of the HIFU technology dating back to 2007. He was credentialed as proctor in 2010 and participated in editing the user manual for the Sonablate HIFU system. Lazar trained FDA investigators on HIFU patient care and was commissioned by SonaCare Medical to proctor FDA clinical trial cases. He has treated or been involved with over 200 patients and is also site director for SonaCare Medical’s international training site in Puerto Vallarta, Mexico. Dr. Lazar has been certified by the American Board of Urology four times and has practiced in Santa Rosa, Calif. since 1983. He is chairman of the Board of Redwood Health Services, Inc. providing insurance products for employee groups. Dr. Lazar is also CEO and managing director [...]
Sonablate HIFU is available now with Dr. Michael Lazar at HIFU Center of Excellence In San Francisco located in downtown San Francisco, 450 Sutter Street, Suite 500, San Francisco, CA 94108 HIFU Center of Excellence offers patients a state-of-the-art facility in downtown that is convenient to hotels and the airport for patients interested in traveling from around the country for this recently FDA-cleared treatment. For more information about HIFU treatment which is now available in San Francisco, or to make an appointment call: (707) 546-5553. Visit us online to learn more at: www.californiahifu.com Physician Practicing HIFU in San Francisco: Dr. Michael Lazar See more on the HIFU Prostate Services Website.
A revolutionary prostate cancer treatment which avoids harming men’s sexual performance could soon be available on the NHS. High Intensity Focused Ultrasound kills the tumour with heat without damaging healthy tissue around it. In an NHS trial led by University College Hospital, London, 625 men were treated. After five years 93% were cancer-free. Only 15% had erectile problems compared with 30 to 60% following surgery. The results were revealed to the European Association of Urology in Munich. Read the full story ...
John McLean brings significant amount of experience in HIFU, operations, marketing and medical imaging. CHARLOTTE, N.C. March 9, 2016. HIFU Prostate Services, LLC, a leading provider of minimally invasive prostate cancer treatments using high intensity focused ultrasound (“HIFU”), is pleased to announce the addition of John McLean as chief operating officer. McLean brings 17 years of experience in healthcare marketing and management to HIFU Prostate Services and will be responsible for managing treatment teams, training programs and marketing initiatives. Prior to joining HIFU Prostate Services, McLean spent eight years at SonaCare Medical where he was involved in approximately 600 HIFU cases. While at SonaCare Medical, McLean served as product manager, business manager and service engineer; he brings experience in all areas of running a successful [...]
The study - on the effectiveness of high-intensity focused ultrasound (HIFU) to treat men with localized prostate cancer - featured at the European Association of Urology Congress (EAU16) in Munich, Germany, March 11-15, 2016. Led by University College Hospital (UCH) in London, UK, the study followed 625 men between 2004-2015, who were treated in the UK and who had localized, non-metastatic tumors; the tumors were in one part of the prostate and had not spread beyond the gland. Hashim Ahmed, a consultant urological surgeon at UCH, told the meeting that 93% of patients who underwent HIFU alone to remove their prostate tumor were still cancer-free and did not need any surgery or radiotherapy 5 years after treatment. The results follow those of an earlier study [...]
A prostate cancer treatment which is rarely offered on the NHS may give patients a 97% chance of survival after five years, a landmark study has suggested. The so-called “male lumpectomy” treatment works by treating just the prostate cancer tumor with High Intensity Focused Ultrasound (HIFU). It is said to have “significantly fewer side effects” than traditional treatments and delivers high rates of cancer control. Prostate cancer is the most commonly diagnosed cancer in men, the second most common cause of cancer-related death in the US and the third most common cause in Europe. While already cleared by the US Food and Drug Administration (FDA), HIFU treatment is only available in very few centres in the NHS. For more information about HIFU available in the [...]
A treatment that uses sound waves to blast away prostate tumors has been proven to cure as many men of the disease as that of the surgery that removes the gland – while causing significantly fewer side effects. Until now the new procedure, called high-intensity focused ultrasound (HIFU), has been considered experimental. This has meant that the majority of British men diagnosed with the condition – including former Rolling Stone Bill Wyman – have only been offered the more invasive operation called radical prostatectomy, which has a clear track record despite the risk of impotence and incontinence. HIFU is a treatment that uses sound waves to blast away prostate tumours has been proven to cure as many men of the disease as surgery that removes [...]
HIFU is making news all over the United States now that it has achieved FDA approval. In the news video below HIFU Prostate Services physician partner, Dr. John Jurige speaks with Louisville's news station, WHAS about HIFU for prostate cancer. Dr. Jurige treated the first patients in the US with HIFU outside of a clinical trial on November 10, 2015. View the video below ... HIFU Prostate Services has partnered with Dr. Michael Lazar and San Francisco Surgery Center to establish a HIFU Center of Excellence in downtown San Franciso where patients can now receive the Sonablate HIFU treatment. Dr. Lazar also serves as Medical Director of HIFU Prostate Services, has been working with HIFU since 2007, and was one of three physicians who proctored [...]